Strong Investment Focus Fountain Healthcare Partners specializes in life sciences, focusing on innovative drugs, devices, and diagnostics that address unmet medical needs, providing opportunities to collaborate with or supply services to rapidly evolving biotech and medtech companies.

Active Capital Raising With over €400 million managed and a recent fund closure in 2025, Fountain is continuously deploying capital into therapeutics and medical device startups, presenting ongoing investment and partnership opportunities.

Geographic Expansion Having offices in Dublin and New York, Fountain is strategically positioned to facilitate cross-continental investments and market entries, opening doors for sales and solutions tailored for European and North American health tech sectors.

Healthy Portfolio Growth Recent investments in biotech and medical device companies like Calypso Biotech, Neuromod Devices, and Inflazome demonstrate an expanding portfolio, indicating opportunities to engage with innovative portfolio companies for sales and support.

Innovation and Market Trends Fountain invests in groundbreaking therapies such as Restorative Neurostimulation and leukemia treatments, aligning with market trends toward personalized, minimally invasive, and neurological health solutions, offering prospects for advanced medical technology partnerships.